Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Buczko

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Medical Care|March 1, 1994
Differences in hospitalizations among seasonal migrants, adjacent-state and in-state aged Medicare beneficiariesW Buczko
Polish Journal of Pharmacology|August 19, 2000
Angiotensin-(1-7). One step forward?W Buczko, I Kucharewicz
Thrombosis Et Diathesis Haemorrhagica|December 31, 1972
Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphineW Buczko, K Wiśniewski
Acta Medica Polona|January 1, 1986
Fibrinogen degradation products do not affect the hypertensive action of dopamineW Buczko, K Wiśniewski
Acta Physiologica Polonica|January 1, 1970
[Use of liver perfusion in rats for the evaluation of metabolism and transport of drugs]K Wiśniewski, W Buczko
Polish Journal of Pharmacology and Pharmacy|May 1, 1977
Influence of fibrinogen degradation products on the action of amphetamine in the central nervous systemJ Zwoliński, W Buczko
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|October 15, 1998
[Erythropoietin and hypertension]A Azzadin, W Buczko
Kardiologia Polska|January 1, 1987
[Serotonin and blood platelets in angiospasm and hypertension]W Buczko, A Beresewicz
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|June 15, 1987
[Atrial natriuretic factor]E Chabielska, W Buczko
Polish Journal of Pharmacology and Pharmacy|September 1, 1979
The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of ratsW Buczko, K Wiśniewski
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Medical Care|March 1, 1994
Differences in hospitalizations among seasonal migrants, adjacent-state and in-state aged Medicare beneficiariesW Buczko
Polish Journal of Pharmacology|August 19, 2000
Angiotensin-(1-7). One step forward?W Buczko, I Kucharewicz
Thrombosis Et Diathesis Haemorrhagica|December 31, 1972
Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphineW Buczko, K Wiśniewski
Acta Medica Polona|January 1, 1986
Fibrinogen degradation products do not affect the hypertensive action of dopamineW Buczko, K Wiśniewski
Acta Physiologica Polonica|January 1, 1970
[Use of liver perfusion in rats for the evaluation of metabolism and transport of drugs]K Wiśniewski, W Buczko
Polish Journal of Pharmacology and Pharmacy|May 1, 1977
Influence of fibrinogen degradation products on the action of amphetamine in the central nervous systemJ Zwoliński, W Buczko
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|October 15, 1998
[Erythropoietin and hypertension]A Azzadin, W Buczko
Kardiologia Polska|January 1, 1987
[Serotonin and blood platelets in angiospasm and hypertension]W Buczko, A Beresewicz
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|June 15, 1987
[Atrial natriuretic factor]E Chabielska, W Buczko
Polish Journal of Pharmacology and Pharmacy|September 1, 1979
The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of ratsW Buczko, K Wiśniewski
Pageof 21